Trademark: 90576653
Word
C
Status Date
Thursday, January 4, 2024
Filing Date
Friday, March 12, 2021
Published for Opposition
Tuesday, November 23, 2021
5 Medicines, medicinal drugs, pharmaceutical drugs, therapeutic pharmaceuticals, pharmaceutical preparations, biologics, biological preparations and therapeutic agents, all for use in the prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions
44 Providing information relating to the diagnostic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; providing a web site featuring medical information; providing medical information; providing health information; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; provision of medical and health information in the field of prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions
42 Scientific research and development services; product research and development; pharmaceutical research and development; conducting clinical trials for others; providing a website featuring information in the field of medical and scientific research, product development, product testing in relation to prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; provision of scientific research information in the field of prevention and treatment of kidney, renal, nephrological, glomerular, and urological diseases, disorders and conditions; providing a website featuring information in the field of medical and scientific research, product development and product testing; providing a website featuring medical and scientific research information in the field of investigational medical diagnostics and drugs; providing a website featuring educational information in the field of clinical research; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing medical and scientific research information in the field of pharmaceuticals
The mark consists of a stylized letter "C" comprised of curved lines depicting stylized wind currents.
Feb 22, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 22, 2024
Teas Change Of Correspondence Received
Feb 22, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 22, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 6, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2024
Sou Extension 4 Granted
Jan 4, 2024
Sou Extension 4 Filed
Jan 4, 2024
Sou Teas Extension Received
Feb 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 7, 2023
Sou Extension 3 Granted
Feb 7, 2023
Sou Extension 3 Filed
Feb 7, 2023
Sou Teas Extension Received
Dec 13, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 9, 2022
Sou Extension 2 Granted
Dec 9, 2022
Sou Extension 2 Filed
Dec 9, 2022
Sou Teas Extension Received
Aug 5, 2022
Teas Change Of Correspondence Received
Aug 5, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 5, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 7, 2022
Sou Extension 1 Granted
Jun 7, 2022
Sou Extension 1 Filed
Jun 7, 2022
Sou Teas Extension Received
May 20, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
May 20, 2022
Teas Change Of Correspondence Received
May 20, 2022
Teas Change Of Owner Address Received
Jan 18, 2022
Noa E-Mailed - Sou Required From Applicant
Nov 23, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 23, 2021
Published For Opposition
Nov 3, 2021
Notification Of Notice Of Publication E-Mailed
Oct 20, 2021
Approved For Pub - Principal Register
Oct 20, 2021
Examiner's Amendment Entered
Oct 20, 2021
Notification Of Examiners Amendment E-Mailed
Oct 20, 2021
Examiners Amendment E-Mailed
Oct 20, 2021
Examiners Amendment -Written
Oct 8, 2021
Assigned To Examiner
Jun 15, 2021
Notice Of Design Search Code E-Mailed
Jun 14, 2021
New Application Office Supplied Data Entered
Mar 16, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
